Cargando…

Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis

Background: Although it is widely known that hypertension is an important cause of chronic kidney disease (CKD), little detailed quantitative research exists on the burden of CKD due to hypertension. Objective: The objective of the study is to estimate the global disease burden of CKD due to hyperte...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Aiming, Zou, Minjie, Young, Charlotte Aimee, Zhu, Weiping, Chiu, Herng-Chia, Jin, Guangming, Tian, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255469/
https://www.ncbi.nlm.nih.gov/pubmed/34235163
http://dx.doi.org/10.3389/fmed.2021.690487
_version_ 1783717912812453888
author Chen, Aiming
Zou, Minjie
Young, Charlotte Aimee
Zhu, Weiping
Chiu, Herng-Chia
Jin, Guangming
Tian, Lin
author_facet Chen, Aiming
Zou, Minjie
Young, Charlotte Aimee
Zhu, Weiping
Chiu, Herng-Chia
Jin, Guangming
Tian, Lin
author_sort Chen, Aiming
collection PubMed
description Background: Although it is widely known that hypertension is an important cause of chronic kidney disease (CKD), little detailed quantitative research exists on the burden of CKD due to hypertension. Objective: The objective of the study is to estimate the global disease burden of CKD due to hypertension and to evaluate the association between the socioeconomic factors and country-level disease burden of CKD due to hypertension. Methods: We extracted the disability-adjusted life-year (DALY) numbers, rates, and age-standardized rates of CKD due to hypertension from the Global Burden of Disease Study 2019 database to investigate the time trends of the burden of CKD due to hypertension from 1990 to 2019. Stepwise multiple linear regression analysis was performed to evaluate the correlations between the age-standardized DALY rate and socioeconomic factors and other related factors obtained from open databases. Results: Globally, from 1990 to 2019, DALY numbers caused by CKD due to hypertension increased by 125.2% [95% confidential interval (CI), 124.6 to 125.7%]. The DALY rate increased by 55.7% (55.3 to 56.0%) to 128.8 (110.9 to 149.2) per 100,000 population, while the age-standardized DALYs per 100,000 population increased by 10.9% (10.3 to 11.5%). In general, males and elderly people tended to have a higher disease burden. The distribution disparity in the burden of CKD due to hypertension varies greatly among countries. In the stepwise multiple linear regression model, inequality-adjusted human development index (IHDI) [β = −161.1 (95% CI −238.1 to −84.2), P < 0.001] and number of physicians per 10,000 people [β = −2.91 (95% CI −4.02 to −1.80), P < 0.001] were significantly negatively correlated with age-standardized DALY rate when adjusted for IHDI, health access and quality (HAQ), number of physicians per 10,000 people, and population with at least some secondary education. Conclusion: Improving the average achievements and equality of distribution in health, education, and income, as well as increasing the number of physicians per 10,000 people could help to reduce the burden of CKD due to hypertension. These findings may provide relevant information toward efforts to optimize health policies aimed at reducing the burden of CKD due to hypertension.
format Online
Article
Text
id pubmed-8255469
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82554692021-07-06 Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis Chen, Aiming Zou, Minjie Young, Charlotte Aimee Zhu, Weiping Chiu, Herng-Chia Jin, Guangming Tian, Lin Front Med (Lausanne) Medicine Background: Although it is widely known that hypertension is an important cause of chronic kidney disease (CKD), little detailed quantitative research exists on the burden of CKD due to hypertension. Objective: The objective of the study is to estimate the global disease burden of CKD due to hypertension and to evaluate the association between the socioeconomic factors and country-level disease burden of CKD due to hypertension. Methods: We extracted the disability-adjusted life-year (DALY) numbers, rates, and age-standardized rates of CKD due to hypertension from the Global Burden of Disease Study 2019 database to investigate the time trends of the burden of CKD due to hypertension from 1990 to 2019. Stepwise multiple linear regression analysis was performed to evaluate the correlations between the age-standardized DALY rate and socioeconomic factors and other related factors obtained from open databases. Results: Globally, from 1990 to 2019, DALY numbers caused by CKD due to hypertension increased by 125.2% [95% confidential interval (CI), 124.6 to 125.7%]. The DALY rate increased by 55.7% (55.3 to 56.0%) to 128.8 (110.9 to 149.2) per 100,000 population, while the age-standardized DALYs per 100,000 population increased by 10.9% (10.3 to 11.5%). In general, males and elderly people tended to have a higher disease burden. The distribution disparity in the burden of CKD due to hypertension varies greatly among countries. In the stepwise multiple linear regression model, inequality-adjusted human development index (IHDI) [β = −161.1 (95% CI −238.1 to −84.2), P < 0.001] and number of physicians per 10,000 people [β = −2.91 (95% CI −4.02 to −1.80), P < 0.001] were significantly negatively correlated with age-standardized DALY rate when adjusted for IHDI, health access and quality (HAQ), number of physicians per 10,000 people, and population with at least some secondary education. Conclusion: Improving the average achievements and equality of distribution in health, education, and income, as well as increasing the number of physicians per 10,000 people could help to reduce the burden of CKD due to hypertension. These findings may provide relevant information toward efforts to optimize health policies aimed at reducing the burden of CKD due to hypertension. Frontiers Media S.A. 2021-06-21 /pmc/articles/PMC8255469/ /pubmed/34235163 http://dx.doi.org/10.3389/fmed.2021.690487 Text en Copyright © 2021 Chen, Zou, Young, Zhu, Chiu, Jin and Tian. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Chen, Aiming
Zou, Minjie
Young, Charlotte Aimee
Zhu, Weiping
Chiu, Herng-Chia
Jin, Guangming
Tian, Lin
Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis
title Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis
title_full Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis
title_fullStr Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis
title_full_unstemmed Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis
title_short Disease Burden of Chronic Kidney Disease Due to Hypertension From 1990 to 2019: A Global Analysis
title_sort disease burden of chronic kidney disease due to hypertension from 1990 to 2019: a global analysis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255469/
https://www.ncbi.nlm.nih.gov/pubmed/34235163
http://dx.doi.org/10.3389/fmed.2021.690487
work_keys_str_mv AT chenaiming diseaseburdenofchronickidneydiseaseduetohypertensionfrom1990to2019aglobalanalysis
AT zouminjie diseaseburdenofchronickidneydiseaseduetohypertensionfrom1990to2019aglobalanalysis
AT youngcharlotteaimee diseaseburdenofchronickidneydiseaseduetohypertensionfrom1990to2019aglobalanalysis
AT zhuweiping diseaseburdenofchronickidneydiseaseduetohypertensionfrom1990to2019aglobalanalysis
AT chiuherngchia diseaseburdenofchronickidneydiseaseduetohypertensionfrom1990to2019aglobalanalysis
AT jinguangming diseaseburdenofchronickidneydiseaseduetohypertensionfrom1990to2019aglobalanalysis
AT tianlin diseaseburdenofchronickidneydiseaseduetohypertensionfrom1990to2019aglobalanalysis